Credo Life Science
Posted on 27th January 2022
Pellet Manufacturing for Global Markets: How Credo Life Sciences Leads the Way
Modified-release drug delivery has transformed modern pharmacotherapy, and at its heart lies pellet manufacturing — one of the most technically demanding and scientifically sophisticated areas of pharmaceutical production. Credo Life Sciences has positioned itself as a leader in Pellet Manufacturing for Global Markets, serving pharma companies across Europe, Asia, the Americas, and beyond.
What is Pharmaceutical Pellet Manufacturing?
Pellets are small, spherical or semi-spherical solid dosage units (typically 0.5–2.0 mm in diameter) that offer several advantages over conventional tablets and capsules. When filled into hard gelatin or HPMC capsules, or compressed into MUPS tablets, pellets provide flexibility in dose modulation, improved bioavailability, and reduced risk of dose dumping. Pellet manufacturing for global markets demands strict adherence to international quality norms while accommodating the regulatory requirements of diverse geographies.
Types of Pellets Manufactured at Credo Life Sciences
- Enteric-Coated Pellets: Protect acid-sensitive drugs (e.g., PPIs) from gastric degradation.
- Extended-Release Pellets: Sustain drug release over 8–24 hours using membrane coating with EC or Eudragit polymers.
- Immediate-Release Pellets: Deliver rapid drug release with enhanced dissolution characteristics.
- Dual-Release Pellets: Two populations providing immediate and delayed drug release in a single capsule.
- Taste-Masked Pellets: Conceal bitter APIs using functional polymer coatings for improved patient compliance.
Why Pellet Manufacturing for Global Markets Requires a Specialised Partner
Regulatory requirements for pellet-based products vary significantly across markets. While ICH guidelines provide a common framework, specific requirements for dissolution testing, stability studies, and impurity profiling differ between USFDA, EMA, WHO-PQ, and national regulatory bodies. A manufacturer experienced in Pellet Manufacturing for Global Markets will navigate these variations efficiently, supporting dossier preparation in multiple formats.
Our Manufacturing Infrastructure
- Multi-compartment fluid bed processors (Wurster column, top-spray, tangential spray)
- High-shear granulators for drug loading
- In-line PAT (Process Analytical Technology) tools for real-time monitoring
- Multi-point dissolution testing systems (pH 1.2, 4.5, 6.8, 7.4)
- Environmental chambers for ICH stability studies (Zone I–IV)
Global Regulatory Support
We support our clients with complete technical documentation — CoA, batch manufacturing records, method validation reports, stability data, and regulatory dossier preparation in CTD (Common Technical Document) format. Our quality systems are built to satisfy US FDA 21 CFR Part 211, EU GMP Annex 11, and WHO-GMP requirements simultaneously.
Credo Life Sciences is your strategic partner for Pellet Manufacturing for Global Markets. With proven technology, rigorous quality systems, and an international regulatory outlook, we help your products succeed in every market you target.